D-2570

N/A

Report date: 2026/05/28 20:00:21
NME

Base Information

Drug NameD-2570
Drug Alias NameD-2570D2570
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase 2 inhibitors
TargetsTyrosine-protein kinase 2
Therapy Area/IndicationsPlaque psoriasisAutoimmune DiseasesPsoriasis +[7
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesInventisbio Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesInventisbio Co Ltd
Inactive CompaniesN/A
Active IndicationsPlaque psoriasisAutoimmune DiseasesPsoriasis +[7
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A